MechChem Africa September-October 2022

Purification products and on-site service for guaranteed cost reductions Veolia Services SouthernAfrica (VSSA), the global specialist in water purification and management, has a range of solutions for the pharmaceutical industry that deliver guaranteed cost reduction, enhanced utilities availability and regulatory compliance. T he pharmaceutical industry is heavily regulated, and all manufac turers must meet the compliance guidelines set out by the various proving access to high quality utilities, especially water. “All our solutions for compendial water production are designed tomeet the product quality specifications of all pharmacopeia requirements and guide lines, giving customers peace of mind and compliance assurance,” says Xu. most from every drop of water’,” explains Leon Xu, Business Development manager for VSSA.

Water source quality remains a potential risk factor for plant performance. “With agingmunicipal water treatment infrastruc ture and a growing urban population, it has become increasingly challenging for themu nicipal works to maintain consistent qual ity at all times. To achieve uninterrupted production of purified water for production use, pharmaceutical manufacturers must ensure that their input water is monitored vigilantly, and that their purified water plants are operated and serviced diligently,” adds Miles Murray, director for Business Development at VSSA. Veolia’s solutions for the pharma ceutical industry deliver cost savings and regulatory c omp l i a n c e , as well as im

pharmacopeia and industry bodies. The qual ity and purity of water – a key component of many medicines – and an essential resource for plant cooling and cleaning, must be guar anteed. However, access to clean water is be coming increasingly costly and difficult to secure. “Water security and input cost are important sustainability factors for phar maceutical manufacturers to consider. It is therefore crucial to employ advanced technologies that enable one to ‘get the

Veolia recently implemented an ultrafil tration system for a pharmaceutical com panywhose purifiedwater treatment plants were failing microbial quality tests. After implementing Veolia’s ultrafiltration system and replacing the purified water treatment system with Veolia Orion ® technology, the company enjoys a secured supply of purified water, resulting from the robust treatment process and hot water sanitisation capabil ity that were put in place. Orion ® is Veolia’s flagship technology that brings together all scientific advances made by Veolia for the pharmaceutical industry. This is a skid-mounted, multi technology purified water production sys tem that offers softening, reverse osmosis and continu- ous electrodeionisation

(CEDI) that can be fully or partially hot water sanitised. “Depending on themodel, theOrion ® system produces be tween 500 and 2 000 litres of purified water per hour. As of today, more than 300 systems have been installed glob ally,” adds Murray. Sustainabi l ity is at

the core of Veo l i a’ s water technologies for the pharmaceut ical indus try. Consider the Orion ® S-Series, which has a recycle mode feature that limits water wastage during purification. During product recy

The Orion ® purified water production system can deliver between 500 and 20 000 ℓ of purified water per hour.

14 ¦ MechChem Africa • September-October 2022